Skip to main content
SpringerLink
Log in

Wirkung von Proteasomeninhibitoren bei der Psoriasis

Ein neues therapeutisches Prinzip?

  • Gehört - Gelesen - Nachgefragt
  • Published:
Der Hautarzt Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Zollner TM, Podda M, Pien C, Elliott PJ, Kaufmann R, Boehnke W-H (2002) Proteasome inhibition reduces superantigen-mediated T cell activation and the severity of psoriasis in a SCID-hu model. J Clin Invest 109:671–679

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. Messer G, Rupec RA (2001) Nuklearfaktor-kappa-B (NF-κB). Teil 1: Funktion und Regulation. Hautarzt 2: 677–685

    Article  Google Scholar 

  3. Messer G, Rupec RA (2001) Nuklearfaktor-kappa-B (NF-κB). Teil 2: Pathophysiologische Bedeutung. Hautarzt 52: 746–753

    Article  CAS  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wirkung von Proteasomeninhibitoren bei der Psoriasis. Hautarzt 53, 445–446 (2002). https://doi.org/10.1007/s00105-002-0403-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00105-002-0403-3

Search

Navigation